Dengue: a continuing global threat
暂无分享,去创建一个
Rosanna W. Peeling | Duane J. Gubler | Philippe Buchy | Sutee Yoksan | Eric Martínez | H. Margolis | R. Peeling | S. Halstead | M. Guzmán | J. Farrar | H. Artsob | D. Gubler | S. Yoksan | P. Buchy | C. Simmons | A. Kroeger | E. Hunsperger | E. Martínez | M. Nathan | J. Pelegrino | Harvey Artsob | Scott B. Halstead | Harold S. Margolis | Axel Kroeger | Jeremy Farrar | Cameron Simmons | Maria G. Guzman | Elizabeth Hunsperger | Michael B. Nathan | Jose Luis Pelegrino
[1] F. Guirakhoo,et al. Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All , 2006, Human vaccines.
[2] A. Nisalak,et al. IgM capture ELISA for detection of IgM antibodies to dengue virus: comparison of 2 formats using hemagglutinins and cell culture derived antigens. , 1992, The Southeast Asian journal of tropical medicine and public health.
[3] R. Lanciotti,et al. Serotype-Specific Detection of Dengue Viruses in a Fourplex Real-Time Reverse Transcriptase PCR Assay , 2005, Journal of Clinical Microbiology.
[4] M. Guzmán,et al. Diagnosis of Dengue Virus Infection by Detection of Specific Immunoglobulin M (IgM) and IgA Antibodies in Serum and Saliva , 2003, Clinical Diagnostic Laboratory Immunology.
[5] M. Guzmán,et al. [Standardization of immunohistochemical techniques for detecting dengue virus antigens in paraffin-embedded tissues]. , 1997, Revista Cubana de Medicina Tropical.
[6] T. Jelínek,et al. Dengue fever in international travelers. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] K. Porter,et al. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques. , 2006, Virology.
[8] M. St. Claire,et al. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention , 2007, Proceedings of the National Academy of Sciences.
[9] K. Johnson. An Update. , 1984, Journal of food protection.
[10] I. Gartside,et al. Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? , 2000, Clinical science.
[11] Denise A. Martin,et al. Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus Vaccination , 2003, Journal of Clinical Microbiology.
[12] A. Barrett,et al. Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. , 2008, Viral immunology.
[13] M. Guzmán,et al. Race: a risk factor for dengue hemorrhagic fever , 2006, Archives of Virology.
[14] A. Nisalak,et al. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. , 1988, The American journal of tropical medicine and hygiene.
[15] P. Marianneau,et al. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. , 1999, Human pathology.
[16] Manuel Ochoa,et al. Effective control of dengue vectors with curtains and water container covers treated with insecticide in Mexico and Venezuela: cluster randomised trials , 2006, British medical journal.
[17] N. White,et al. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? , 2001, The Journal of infectious diseases.
[18] C. King,et al. Flow Cytometry Compared with Indirect Immunofluorescence for Rapid Detection of Dengue Virus Type 1 after Amplification in Tissue Culture , 2001, Journal of Clinical Microbiology.
[19] S. Kalayanarooj,et al. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. , 2007, The Journal of general virology.
[20] J. Hombach. Vaccines against dengue: a review of current candidate vaccines at advanced development stages. , 2007, Revista panamericana de salud publica = Pan American journal of public health.
[21] N. White,et al. Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. , 2002, The American journal of tropical medicine and hygiene.
[22] M. Guzmán,et al. Apoptosis in tissues from fatal dengue shock syndrome. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[23] S. Higgs,et al. Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection. , 2004, Viral immunology.
[24] M. Guzmán,et al. Dengue: an update. , 2002, The Lancet. Infectious diseases.
[25] M. Guzmán,et al. Fatal dengue hemorrhagic fever in Cuba, 1997. , 1999, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[26] C. Romero-Vivas,et al. Altered Enzyme-Linked Immunosorbent Assay Immunoglobulin M (IgM)/IgG Optical Density Ratios Can Correctly Classify All Primary or Secondary Dengue Virus Infections 1 Day after the Onset of Symptoms, when All of the Viruses Can Be Isolated , 2006, Clinical and Vaccine Immunology.
[27] Tao Dong,et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.
[28] M. C. Williams,et al. Dengue in the Caribbean: virus isolation in a mosquito (Aedes pseudoscutellaris) cell line. , 1979, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[29] J. Bisset,et al. LEVELS OF INSECTICIDE RESISTANCE AND RESISTANCE MECHANISMS IN AEDES AEGYPTI FROM SOME LATIN AMERICAN COUNTRIES , 2007, Journal of the American Mosquito Control Association.
[30] A. Nisalak,et al. Comparison of four reverse transcription-polymerase chain reaction procedures for the detection of dengue virus in clinical specimens. , 2002, Journal of virological methods.
[31] S. Halstead,et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. , 2001, The American journal of tropical medicine and hygiene.
[32] S. Halstead,et al. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. , 2005, Vaccine.
[33] K. Yuen,et al. Serotype 1-Specific Monoclonal Antibody-Based Antigen Capture Immunoassay for Detection of Circulating Nonstructural Protein NS1: Implications for Early Diagnosis and Serotyping of Dengue Virus Infections , 2006, Journal of Clinical Microbiology.
[34] D. Gubler,et al. Impact of dengue/dengue hemorrhagic fever on the developing world. , 1999, Advances in virus research.
[35] Tyen‐Po Chen,et al. Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[36] C. Villarreal-Garza,et al. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. , 2002, Human immunology.
[37] S. Watowich,et al. Evolutionary Relationships of Endemic/Epidemic and Sylvatic Dengue Viruses , 2000, Journal of Virology.
[38] E. Torres. La prevención de la mortalidad por dengue: un espacio y un reto para la atención primaria de salud , 2006 .
[39] M. Guzmán,et al. A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. , 2006, Vaccine.
[40] M. Mulla,et al. Mosquito burden and impact on the poor: measures and costs for personal protection in some communities in Thailand. , 2001, Journal of the American Mosquito Control Association.
[41] D. Gubler,et al. Dengue and dengue haemorrhagic fever , 1998, The Lancet.
[42] I. Kurane,et al. Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[43] S. Halstead. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. , 1979, The Journal of infectious diseases.
[44] S. Nimmannitya,et al. Clinical spectrum and management of dengue haemorrhagic fever. , 1987, The Southeast Asian journal of tropical medicine and public health.
[45] D. Gubler,et al. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? , 2004, Comparative immunology, microbiology and infectious diseases.
[46] J. Farrar,et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. , 2007, The Journal of infectious diseases.
[47] Chwan-Chuen King,et al. Detection of Dengue Viral RNA Using a Nucleic Acid Sequence-Based Amplification Assay , 2001, Journal of Clinical Microbiology.
[48] S. Halstead,et al. Original antigenic sin in dengue. , 1983, The American journal of tropical medicine and hygiene.
[49] S. Halstead,et al. Do escape mutants explain rapid increases in dengue casefatality rates within epidemics? , 2000, The Lancet.
[50] Laura D. Kramer,et al. Typing of Dengue Viruses in Clinical Specimens and Mosquitoes by Single-Tube Multiplex Reverse Transcriptase PCR , 1998, Journal of Clinical Microbiology.
[51] S. Halstead,et al. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization , 1985, Journal of clinical microbiology.
[52] Cameron P Simmons,et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. , 2010, Cell host & microbe.
[53] Ting-Hsiang Lin,et al. Comparison of Capture Immunoglobulin M (IgM) and IgG Enzyme-Linked Immunosorbent Assay (ELISA) and Nonstructural Protein NS1 Serotype-Specific IgG ELISA for Differentiation of Primary and Secondary Dengue Virus Infections , 2003, Clinical Diagnostic Laboratory Immunology.
[54] M. Cardosa,et al. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. , 2002, BMC Microbiology.
[55] Rosanna W. Peeling,et al. Evaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests , 2009, Emerging infectious diseases.
[56] K. Wong,et al. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. , 2004, The Journal of infectious diseases.
[57] B. Murphy,et al. Prospects for a dengue virus vaccine , 2007, Nature Reviews Microbiology.
[58] M. Guzmán,et al. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[59] T. Jelínek,et al. Dengue Antibody Prevalence in German Travelers , 2005, Emerging Infectious Diseases.
[60] Susana Vázquez,et al. Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. , 2006, The American journal of tropical medicine and hygiene.
[61] S. Devi,et al. Rapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR. , 2006, Journal of virological methods.
[62] V. S. Nam,et al. National progress in dengue vector control in Vietnam: survey for Mesocyclops (Copepoda), Micronecta (Corixidae), and fish as biological control agents. , 2000, The American journal of tropical medicine and hygiene.
[63] J. Morgan,et al. Pyrethroid and DDT cross‐resistance in Aedes aegypti is correlated with novel mutations in the voltage‐gated sodium channel gene , 2003, Medical and veterinary entomology.
[64] Angel Balmaseda,et al. Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. , 2005, The American journal of tropical medicine and hygiene.
[65] S. Halstead,et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. , 2000, American journal of epidemiology.
[66] C. Peters,et al. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. , 1991, The American journal of tropical medicine and hygiene.
[67] A. Kroeger,et al. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever , 2006, Tropical medicine & international health : TM & IH.
[68] L. Rosen,et al. Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. , 1999, The American journal of tropical medicine and hygiene.
[69] Anavaj Sakuntabhai,et al. A variant in the CD209 promoter is associated with severity of dengue disease , 2005, Nature Genetics.
[70] D. Focks. Multicountry study of Aedes aegypti pupal productivity survey methodology : Findings and recommendations , 2006 .
[71] M. Guzmán,et al. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. , 1990, The American journal of tropical medicine and hygiene.
[72] L. Lloyd,et al. Planning social mobilization and communication for dengue fever prevention and control: a step-by-step guide. , 2004 .
[73] Z. Layrisse,et al. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. , 2004, Tissue antigens.
[74] G. Kuno,et al. An ELISA procedure for the diagnosis of dengue infections. , 1991, Journal of virological methods.
[75] A. Nisalak,et al. The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[76] A. Nisalak,et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. , 2002, Tissue antigens.
[77] S. Nimmannitya,et al. Nutritional status of children with dengue hemorrhagic fever. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[78] J. Gruenberg,et al. The Secreted Form of Dengue Virus Nonstructural Protein NS1 Is Endocytosed by Hepatocytes and Accumulates in Late Endosomes: Implications for Viral Infectivity , 2005, Journal of Virology.
[79] J. Lang,et al. A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. , 2010, The Journal of infectious diseases.
[80] A. Nisalak,et al. Dengue virus identification by the plaque reduction neutralization test. , 1967, Journal of immunology.
[81] R. Lanciotti,et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.
[82] A. Barrett,et al. Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. , 2007, Vaccine.
[83] M. Guzmán,et al. Dengue diagnosis, advances and challenges. , 2004, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[84] R. Karron,et al. rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers , 2005 .
[85] HUmAN SERvICES,et al. International Health Regulations. , 1971, British medical journal.
[86] M. Seguin,et al. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. , 1983, The American journal of tropical medicine and hygiene.
[87] Duane J. Gubler,et al. Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.
[88] D. Gubler,et al. Dengue and dengue hemorrhagic fever in the Americas. , 1987, Puerto Rico health sciences journal.
[89] M. V. Cabrera,et al. IgM antibodies to dengue virus in dried blood on filter paper. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[90] V. S. Nam,et al. Control of aedes vectors of dengue in three provinces of Vietnam by use of Mesocyclops (Copepoda) and community-based methods validated by entomologic, clinical, and serological surveillance. , 2002, The American journal of tropical medicine and hygiene.
[91] R. Rico-Hesse. Microevolution and virulence of dengue viruses. , 2003, Advances in virus research.
[92] Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response. , 2004, The American journal of tropical medicine and hygiene.
[93] Ira B Schwartz,et al. Dynamic effects of antibody-dependent enhancement on the fitness of viruses. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[94] Alan L Rothman,et al. Dengue: defining protective versus pathologic immunity. , 2004, The Journal of clinical investigation.
[95] D. Gubler,et al. Dengue and dengue hemorrhagic fever. , 2014 .
[96] G. Chang,et al. Development of Real-Time Reverse Transcriptase PCR Assays To Detect and Serotype Dengue Viruses , 2006, Journal of Clinical Microbiology.
[97] B. Murphy,et al. A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys , 2003, Journal of Virology.
[98] M. Guzmán,et al. Detección de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro , 1998 .
[99] T. Osawa,et al. Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans , 2010 .
[100] P. S. Thangaratham,et al. Indian perspective on the need for new case definitions of severe dengue. , 2007, The Lancet. Infectious diseases.
[101] SB Halstead,et al. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody , 1977, The Journal of experimental medicine.
[102] A. Paulen. A time for reassessment. , 1986, Cancer nursing.
[103] M. Blettner,et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. , 2006, The Journal of infectious diseases.
[104] A. Nisalak,et al. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance. , 2009, The American journal of tropical medicine and hygiene.
[105] M. Saeed,et al. Dengue and Dengue Hemorrhagic Fever , 2015 .
[106] P. Young,et al. An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients , 2000, Journal of Clinical Microbiology.
[107] B. McKinney,et al. Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers. , 2009, The American journal of tropical medicine and hygiene.
[108] S. Halstead,et al. Dengue virus-mosquito interactions. , 2008, Annual review of entomology.
[109] M. Guzmán,et al. Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. , 2006, Viral immunology.
[110] M. Guzmán,et al. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[111] D. Vaughn,et al. Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. , 2003, The American journal of tropical medicine and hygiene.
[112] J. Mascola,et al. Human skin Langerhans cells are targets of dengue virus infection , 2000, Nature Medicine.
[113] R. Bos. Global Strategic Framework for Integrated Vector Management , 2004 .
[114] S. Halstead,et al. Effect of age on outcome of secondary dengue 2 infections. , 2002, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[115] A. Nisalak,et al. Blood group AB is associated with increased risk for severe dengue disease in secondary infections. , 2007, The Journal of infectious diseases.
[116] K. Morita,et al. Rapid identification of dengue virus serotypes by using polymerase chain reaction , 1991, Journal of clinical microbiology.
[117] P. Malasit. Complement and dengue haemorrhagic fever/shock syndrome. , 1987, The Southeast Asian journal of tropical medicine and public health.
[118] M. Guzmán,et al. Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[119] D. Pérez,et al. What do community-based dengue control programmes achieve? A systematic review of published evaluations. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[120] A. Nisalak,et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. , 1989, The American journal of tropical medicine and hygiene.
[121] Jacqueline L Deen,et al. The WHO dengue classification and case definitions: time for a reassessment , 2006, The Lancet.
[122] S. Halstead,et al. Virus evolution during a severe dengue epidemic in Cuba, 1997. , 2005, Virology.
[123] Eli Schwartz,et al. Dengue in travelers. , 2005, The New England journal of medicine.
[124] A. Nisalak,et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.
[125] B. A. Harrison,et al. Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. , 1987, The American journal of tropical medicine and hygiene.
[126] A. di Caro,et al. Recent expansion of dengue virus serotype 3 in West Africa. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[127] Susana Vázquez,et al. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. , 2002, Revista panamericana de salud publica = Pan American journal of public health.
[128] A. Nisalak,et al. Prospective Study To Determine Accuracy of Rapid Serological Assays for Diagnosis of Acute Dengue Virus Infection in Laos , 2007, Clinical and Vaccine Immunology.
[129] M. Cetron,et al. Spectrum of disease and relation to place of exposure among ill returned travelers. , 2006, The New England journal of medicine.
[130] Ting-Hsiang Lin,et al. Potential Application of Nonstructural Protein NS1 Serotype-Specific Immunoglobulin G Enzyme-Linked Immunosorbent Assay in the Seroepidemiologic Study of Dengue Virus Infection: Correlation of Results with Those of the Plaque Reduction Neutralization Test , 2002, Journal of Clinical Microbiology.
[131] J. Rigau-Pérez,et al. Severe dengue: the need for new case definitions. , 2006, The Lancet. Infectious diseases.
[132] Yee‐Shin Lin,et al. Autoimmune pathogenesis in dengue virus infection. , 2006, Viral immunology.
[133] M. Guzmán,et al. ELISA de inhibición: Su utilidad para clasificar un caso de dengue , 1997 .
[134] N. Karabatsos,et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.